Pharmaco - Press Releases

Date	Title	Company
13-May-2020	Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes	MEI Pharma, Inc.
13-May-2020	Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at ASCO 2020 Annual Meeting	Marker Therapeutics, Inc.
13-May-2020	Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program	Sanofi
13-May-2020	Lilly Oncology Showcases Innovation in Cancer Research at ASCO 2020	Eli Lilly and Company
13-May-2020	Amgen Showcases Oncology Pipeline At ASCO 2020	Amgen
13-May-2020	Regeneron Presentations at ASCO 2020 Showcase Diverse Clinical Oncology Portfolio	Regeneron Pharmaceuticals, Inc.
13-May-2020	Polynoma Presenting Final Analysis of MAVIS Phase III Part B1 Data of Its Investigational Melanoma Vaccine, Seviprotimut-L, at ASCO20 Virtual Scientific Program	Polynoma LLC
13-May-2020	Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19	Hetero
13-May-2020	Micro Labs USA Inc and Saptalis Pharmaceuticals LLC Announce Launch of Metformin Oral Solution (500 mg/5mL in two presentations 118mL and 473mL)	Micro Labs USA
13-May-2020	ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results	ADVANZ PHARMA Corp.
13-May-2020	BioMed X Institute Launches Rapid Antiviral Response Platform to Prevent Future Pandemics	B3C newswire
13-May-2020	Polyganics Awarded €1.2 Million for Clinical Development of Liver and Pancreas Sealant Patch	B3C newswire
13-May-2020	Medios AG: Secondary placement oversubscribed several times - Free float over 60%	Medios AG
13-May-2020	PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2020	PAION AG
12-May-2020	Syndax Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares	Syndax Pharmaceuticals, Inc.
12-May-2020	Penumbra Announces Management Transition	Penumbra, Inc.
12-May-2020	Medios AG: Increase of free float through secondary placement envisaged - Admission to Prime Standard applied for	Medios AG
12-May-2020	MPH Health Care AG: Supervisory Board approves 2019 financial statements. Proposal of the Executive Board to carry forward the entire 2019 balance sheet profit confirmed.	MPH Health Care AG
12-May-2020	China Biologic Products to Report First Quarter 2020 Financial Results	China Biologic Products Holdings, Inc.
12-May-2020	TPX-100: OrthoTrophix Presents More Evidence for Disease Modification in Knee Osteoarthritis in a New Abstract Published in Osteoarthritis & Cartilage Journal	OrthoTrophix, Inc.